Aberrant Expression of and in Infrapatellar Fat Pad-Derived ASCs from Pre-Diabetic Donors

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Aug 12

PMID 35954211

Authors

Benjamen T ODonnell

Tia A Monjure

Sara Al-Ghadban

Clara J Ives

Michael P LEcuyer

Claire Rhee

Monica Romero-Lopez

Zhong Li

Stuart B Goodman

Hang Lin

Rocky S Tuan

Bruce A Bunnell

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis (OA) is a degenerative joint disease resulting in limited mobility and severe disability. Type II diabetes mellitus (T2D) is a weight-independent risk factor for OA, but a link between the two diseases has not been elucidated. Adipose stem cells (ASCs) isolated from the infrapatellar fat pad (IPFP) may be a viable regenerative cell for OA treatment. This study analyzed the expression profiles of inflammatory and adipokine-related genes in IPFP-ASCs of non-diabetic (Non-T2D), pre-diabetic (Pre-T2D), and T2D donors. Pre-T2D ASCs exhibited a substantial decrease in levels of mesenchymal markers CD90 and CD105 with no change in adipogenic differentiation compared to Non-T2D and T2D IPFP-ASCs. In addition, Cyclooxygenase-2 (), Forkhead box G1 () expression and prostaglandin E2 (PGE) secretion were significantly increased in Pre-T2D IPFP-ASCs upon stimulation by interleukin-1 beta (IL-1β). Interestingly, M1 macrophages exhibited a significant reduction in expression of pro-inflammatory markers and when co-cultured with Pre-T2D IPFP-ASCs. These data suggest that the heightened systemic inflammation associated with untreated T2D may prime the IPFP-ASCs to exhibit enhanced anti-inflammatory characteristics via suppressing the IL-6/COX-2 signaling pathway. In addition, the elevated production of PGE by the Pre-T2D IPFP-ASCs may also suggest the contribution of pre-diabetic conditions to the onset and progression of OA.

Citing Articles

The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.

Maiese K Front Immunol. 2023; 14:1273570.

PMID: 38022638 PMC: 10663950. DOI: 10.3389/fimmu.2023.1273570.

Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.

Maiese K Cells. 2023; 12(22).

PMID: 37998330 PMC: 10670256. DOI: 10.3390/cells12222595.

Innovative therapeutic strategies for cardiovascular disease.

Maiese K EXCLI J. 2023; 22:690-715.

PMID: 37593239 PMC: 10427777. DOI: 10.17179/excli2023-6306.

Cognitive Impairment in Multiple Sclerosis.

Maiese K Bioengineering (Basel). 2023; 10(7).

PMID: 37508898 PMC: 10376413. DOI: 10.3390/bioengineering10070871.

The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.

Maiese K Curr Neurovasc Res. 2023; 20(3):314-333.

PMID: 37488757 PMC: 10528135. DOI: 10.2174/1567202620666230721122957.

References

Lin Z, Li Z, Li E, Li X, Del Duke C, Shen H . Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs. Front Bioeng Biotechnol. 2020; 7:411. PMC: 6930794. DOI: 10.3389/fbioe.2019.00411. View

Alicka M, Major P, Wysocki M, Marycz K . Adipose-Derived Mesenchymal Stem Cells Isolated from Patients with Type 2 Diabetes Show Reduced "Stemness" through an Altered Secretome Profile, Impaired Anti-Oxidative Protection, and Mitochondrial Dynamics Deterioration. J Clin Med. 2019; 8(6). PMC: 6617220. DOI: 10.3390/jcm8060765. View

Suri S, Gill S, Massena de Camin S, Wilson D, McWilliams D, Walsh D . Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007; 66(11):1423-8. PMC: 2111605. DOI: 10.1136/ard.2006.063354. View

Deshpande B, Katz J, Solomon D, Yelin E, Hunter D, Messier S . Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res (Hoboken). 2016; 68(12):1743-1750. PMC: 5319385. DOI: 10.1002/acr.22897. View

Skalska U, Kontny E, Prochorec-Sobieszek M, Maslinski W . Intra-articular adipose-derived mesenchymal stem cells from rheumatoid arthritis patients maintain the function of chondrogenic differentiation. Rheumatology (Oxford). 2012; 51(10):1757-64. DOI: 10.1093/rheumatology/kes129. View

Goldring M, Birkhead J, Suen L, Yamin R, Mizuno S, Glowacki J . Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest. 1994; 94(6):2307-16. PMC: 330059. DOI: 10.1172/JCI117595. View

Griffin T, Scanzello C . Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin Exp Rheumatol. 2019; 37 Suppl 120(5):57-63. PMC: 6842324. View

Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J . Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2012; 36(2):403-9. PMC: 3554306. DOI: 10.2337/dc12-0924. View

ODonnell B, Al-Ghadban S, Ives C, LEcuyer M, Monjure T, Romero-Lopez M . Adipose Tissue-Derived Stem Cells Retain Their Adipocyte Differentiation Potential in Three-Dimensional Hydrogels and Bioreactors . Biomolecules. 2020; 10(7). PMC: 7408056. DOI: 10.3390/biom10071070. View

10.

Macchi V, Stocco E, Stecco C, Belluzzi E, Favero M, Porzionato A . The infrapatellar fat pad and the synovial membrane: an anatomo-functional unit. J Anat. 2018; 233(2):146-154. PMC: 6036933. DOI: 10.1111/joa.12820. View

11.

Sommer C, Kress M . Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004; 361(1-3):184-7. DOI: 10.1016/j.neulet.2003.12.007. View

12.

Liu Y, Buckley C, Almeida H, Mulhall K, Kelly D . Infrapatellar fat pad-derived stem cells maintain their chondrogenic capacity in disease and can be used to engineer cartilaginous grafts of clinically relevant dimensions. Tissue Eng Part A. 2014; 20(21-22):3050-62. PMC: 4229863. DOI: 10.1089/ten.TEA.2014.0035. View

13.

Arden K . FoxO: linking new signaling pathways. Mol Cell. 2004; 14(4):416-8. DOI: 10.1016/s1097-2765(04)00213-8. View

14.

Ballegaard C, Riis R, Bliddal H, Christensen R, Henriksen M, Bartels E . Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage. 2014; 22(7):933-40. DOI: 10.1016/j.joca.2014.04.018. View

15.

Bouffi C, Bony C, Courties G, Jorgensen C, Noel D . IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One. 2010; 5(12):e14247. PMC: 2998425. DOI: 10.1371/journal.pone.0014247. View

16.

Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton J . Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017; 5:16044. PMC: 5240031. DOI: 10.1038/boneres.2016.44. View

17.

Bondeson J, Wainwright S, Lauder S, Amos N, Hughes C . The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther. 2006; 8(6):R187. PMC: 1794533. DOI: 10.1186/ar2099. View

18.

Arendt-Nielsen L, Egsgaard L, Petersen K . Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. Pain. 2016; 157(8):1634-1644. DOI: 10.1097/j.pain.0000000000000562. View

19.

Yanez R, Oviedo A, Aldea M, Bueren J, Lamana M . Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res. 2010; 316(19):3109-23. DOI: 10.1016/j.yexcr.2010.08.008. View

20.

Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J . Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther. 2000; 6(2):71-9. DOI: 10.1080/13684730050515796. View